These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 20452455

  • 1. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
    El Ridi R, Tallima H, Mahana N, Dalton JP.
    Microbes Infect; 2010 Sep; 12(10):700-9. PubMed ID: 20452455
    [Abstract] [Full Text] [Related]

  • 2. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R, Tallima H.
    Vaccine; 2009 Jan 29; 27(5):666-73. PubMed ID: 19056448
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant selection for vaccination against murine schistosomiasis.
    El Ridi R, Tallima H.
    Scand J Immunol; 2012 Dec 29; 76(6):552-8. PubMed ID: 22882457
    [Abstract] [Full Text] [Related]

  • 4. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
    El Ridi R, Tallima H.
    J Parasitol; 2013 Apr 29; 99(2):194-202. PubMed ID: 22985345
    [Abstract] [Full Text] [Related]

  • 5. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.
    Mountford AP, Anderson S, Wilson RA.
    J Immunol; 1996 Jun 15; 156(12):4739-45. PubMed ID: 8648120
    [Abstract] [Full Text] [Related]

  • 6. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H, Tadros MM, El Ridi R.
    Acta Trop; 2024 Jun 15; 254():107208. PubMed ID: 38621620
    [Abstract] [Full Text] [Related]

  • 7. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, de Melo AL, Caliari MV, Almeida GT, Venancio TM, Verjovski-Almeida S, Oliveira SC.
    PLoS Negl Trop Dis; 2008 Oct 01; 2(10):e308. PubMed ID: 18827884
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.
    Wynn TA, Oswald IP, Eltoum IA, Caspar P, Lowenstein CJ, Lewis FA, James SL, Sher A.
    J Immunol; 1994 Dec 01; 153(11):5200-9. PubMed ID: 7525727
    [Abstract] [Full Text] [Related]

  • 10. Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection.
    Araujo JM, de Melo TT, de Sena IC, Alves CC, Araujo N, Durães Fdo V, Oliveira SC, Fonseca CT.
    Acta Trop; 2012 Nov 01; 124(2):140-6. PubMed ID: 22842304
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.
    Hernandez HJ, Wang Y, Stadecker MJ.
    J Immunol; 1997 May 15; 158(10):4832-7. PubMed ID: 9144498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.
    Pemberton RM, Wilson RA.
    Immunology; 1995 Feb 15; 84(2):310-6. PubMed ID: 7751008
    [Abstract] [Full Text] [Related]

  • 15. Schistosoma mansoni schistosomula antigens induce Th1/Pro-inflammatory cytokine responses.
    Egesa M, Lubyayi L, Tukahebwa EM, Bagaya BS, Chalmers IW, Wilson S, Hokke CH, Hoffmann KF, Dunne DW, Yazdanbakhsh M, Labuda LA, Cose S.
    Parasite Immunol; 2018 Dec 15; 40(12):e12592. PubMed ID: 30239006
    [Abstract] [Full Text] [Related]

  • 16. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO, Johansson M, Lövgren-Bengtson K, Hau J.
    Scand J Immunol; 2000 Mar 15; 51(3):237-43. PubMed ID: 10736092
    [Abstract] [Full Text] [Related]

  • 17. Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice.
    Morais SB, Figueiredo BC, Assis NRG, Homan J, Mambelli FS, Bicalho RM, Souza C, Martins VP, Pinheiro CS, Oliveira SC.
    Front Immunol; 2018 Mar 15; 9():1762. PubMed ID: 30105029
    [Abstract] [Full Text] [Related]

  • 18. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
    Hoffmann KF, James SL, Cheever AW, Wynn TA.
    J Immunol; 1999 Jul 15; 163(2):927-38. PubMed ID: 10395689
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.
    Martins VP, Pinheiro CS, Figueiredo BC, Assis NR, Morais SB, Caliari MV, Azevedo V, Castro-Borges W, Wilson RA, Oliveira SC.
    Clin Dev Immunol; 2012 Jul 15; 2012():962538. PubMed ID: 22927873
    [Abstract] [Full Text] [Related]

  • 20. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
    Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, Le L, Siddiqui AA.
    Parasitol Res; 2009 Nov 15; 105(6):1767-77. PubMed ID: 19809833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.